Secondary lipid accumulation in lysosomal disease

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1793, Issue 4, 2009, Pages 726-736

  Walkley, Steven U ^a   Vanier, Marie T ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b INSERM   (France)

Author keywords

Bis(monoacylglycero)phosphate; Cholesterol; Ganglioside; Glucosylceramide; Glycosphingolipid; Lactosylceramide; Phospholipid; Sphingolipid; Sphingomyelin

Indexed keywords

CHOLESTEROL; GLUCOSYLCERAMIDE; GLYCOSPHINGOLIPID; LACTOSYLCERAMIDE; PHOSPHOLIPID; SPHINGOMYELIN;

CYTOLOGY; GANGLIOSIDOSIS; HUMAN; HURLER SYNDROME; LIPID STORAGE; LIPIDOSIS; LYSOSOME STORAGE DISEASE; MUCOPOLYSACCHARIDOSIS; NIEMANN PICK DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SANFILIPPO SYNDROME;

ANIMALS; BIOLOGICAL MARKERS; HUMANS; LIPID METABOLISM; LYSOSOMAL STORAGE DISEASES;

EID: 62949156035     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.11.014     Document Type: Review

References (137)

1. Platt F.M., and Walkley S.U. Lysosomal defects and storage. In: Platt F.M., and Walkley S.U. (Eds). Lysosomal Disorders of the Brain (2004), Oxford University Press, Oxford 32-49
2. Cumings J.N. Abnormalities in lipid metabolism in two members of a family with Niemann-Pick disease. In: Aronson S.M., and Volk B.W. (Eds). Cerebral lipidoses (1962), Academic Press, New York 171-178
3. Kamoshita S., Aron A.M., Suzuki K., and Suzuki K. Infantile Niemann-Pick disease. A chemical study with isolation and characterization of membranous cytoplasmic bodies and myelin. Am. J. Dis. Child 117 (1969) 379-394
4. Martin J.J., Philippart M., Van Hauwaert J., Callahan J.W., and Deberdt R. Niemann-Pick disease (Crocker's group A). Late onset and pigmentary degeneration resembling Hallervorden-Spatz syndrome. Arch. Neurol. 27 (1972) 45-51
5. Brunngraber E.G., Berra B., and Zambotti V. Altered levels of tissue glycoproteins, gangliosides, glycosaminoglycans and lipids in Niemann-Pick's disease. Clin. Chim. Acta 48 (1973) 173-181
6. Rodriguez-Lafrasse C., and Vanier M.T. Sphingosylphosphorylcholine in Niemann-Pick disease brain: accumulation in type A but not in type B. Neurochem. Res. 24 (1999) 199-205
7. Crocker A.C. The cerebral defect in Tay-Sachs disease and Niemann-Pick disease. J. Neurochem. 7 (1961) 69-80
8. Philippart M., Martin L., Martin J.J., and Menkes J.H. Niemann-Pick disease. Morphologic and biochemical studies in the visceral form with late central nervous system involvement (Crocker's group C). Arch. Neurol. 20 (1969) 227-238
9. Tjiong H.B., Seng P.N., Debuch H., and Wiedemann H.R. Brain lipids of a case of juvenile Niemann-Pick disease. J. Neurochem. 21 (1973) 1475-1485
10. Harzer K., Schlote W., Peiffer J., Benz H.U., and Anzil A.P. Neurovisceral lipidosis compatible with Niemann-Pick disease type C: morphological and biochemical studies of a late infantile case and enzyme and lipid assays in a prenatal case of the same family. Acta Neuropathol. (Berl) 43 (1978) 97-104
11. Elleder M., Jirasek A., Smid F., Ledvinova J., and Besley G.T. Niemann-Pick disease type C. Study on the nature of the cerebral storage process. Acta Neuropathol. (Berl) 66 (1985) 325-336
12. Elleder M. Niemann-Pick disease. Pathol. Res. Pract. 185 (1989) 293-328
13. Vanier M.T. Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature. Neurochem. Res. 24 (1999) 481-489
14. Pentchev P.G., Gal A.E., Booth A.D., Omodeo-Sale F., Fouks J., Neumeyer B.A., Quirk J.M., Dawson G., and Brady R.O. A lysosomal storage disorder in mice characterized by a dual deficiency of sphingomyelinase and glucocerebrosidase. Biochim. Biophys. Acta 619 (1980) 669-679
15. Sleat D.E., Wiseman J.A., El Banna M., Price S.M., Verot L., Shen M.M., Tint G.S., Vanier M.T., Walkley S.U., and Lobel P. Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 5886-5891
16. Wenger D.A., Kudoh T., Sattler M., Palmieri M., and Yudkoff M. Niemann-Pick disease type B: prenatal diagnosis and enzymatic and chemical studies on fetal brain and liver. Am. J. Hum. Genet. 33 (1981) 337-344
17. Vanier M.T., Boue J., and Dumez Y. Niemann-Pick disease type B: first-trimester prenatal diagnosis on chorionic villi and biochemical study of a foetus at 12 weeks of development. Clin. Genet. 28 (1985) 348-354
18. Vanier M.T., Pentchev P.G., and Rousson R. Pathophysiological approach of Niemann-Pick disease type C; definition of a biochemical heterogeneity and reevaluation of the lipid storage process. In: Salvayre R., Douste-Blazy L., and Gatt S. (Eds). Lipid Storage Disorders: Biological and Medical Aspects. Series A: Life Sciences vol. 150 (1988), Plenum Press, New York 175-185
19. Fujita N., Suzuki K., Vanier M.T., Popko B., Maeda N., Klein A., Henseler M., Sandhoff K., Nakayasu H., and Suzuki K. Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids. Hum. Mol. Genet. 5 (1996) 711-725
20. Hulkova H., Cervenkova M., Ledvinova J., Tochackova M., Hrebicek M., Poupetova H., Befekadu A., Berna L., Paton B.C., Harzer K., Boor A., Smid F., and Elleder M. A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation. Hum. Mol. Genet. 10 (2001) 927-940
21. Jabs S., Quitsch A., Kakela R., Koch B., Tyynela J., Brade H., Glatzel M., Walkley S., Saftig P., Vanier M.T., and Braulke T. Accumulation of bis(monoacylglycero)phosphate and gangliosides in mouse models of neuronal ceroid lipofuscinosis. J. Neurochem. 106 (2008) 1415-1425
22. Constantopoulos G., and Dekaban A.S. Neurochemistry of the mucopolysaccharidoses: brain lipids and lysosomal enzymes in patients with four types of mucopolysaccharidosis and in normal controls. J. Neurochem. 30 (1978) 965-973
23. Constantopoulos G., Iqbal K., and Dekaban A.S. Mucopolysaccharidosis types IH, IS, II, and IIIA: glycosaminoglycans and lipids of isolated brain cells and other fractions from autopsied tissues. J. Neurochem. 34 (1980) 1399-1411
24. Van Dessel G., Lagrou A., Martin J.J., Ceuterick C., and Dierick W. Two cases of mucopolysaccharidosis type III (Sanfilippo). A biochemical study. J. Neurol. Sci. 40 (1979) 77-86
25. Hara A., Kitazawa N., and Taketomi T. Abnormalities of glycosphingolipids in mucopolysaccharidosis type III B. J. Lipid Res. 25 (1984) 175-184
26. Li H.H., Yu W.H., Rozengurt N., Zhao H.Z., Lyons K.M., Anagnostaras S., Fanselow M.S., Suzuki K., Vanier M.T., and Neufeld E.F. Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase. Proc. Natl. Acad. Sci. U. S. A 96 (1999) 14505-14510
27. Bermudez A.J., Johnson G.C., Vanier M.T., Schroder M., Suzuki K., Stogsdill P.L., Johnson G.S., O'Brien D., Moore C.P., and Fry W.W. Gangliosidosis in emus (Dromaius novaehollandiae). Avian Dis 39 (1995) 292-303
28. Constantopoulos G., Shull R.M., Hastings N., and Neufeld E.F. Neurochemical characterization of canine alpha-L-iduronidase deficiency disease (model of human mucopolysaccharidosis I). J. Neurochem. 45 (1985) 1213-1217
29. Siegel D.A., and Walkley S.U. Growth of ectopic dendrites on cortical pyramidal neurons in neuronal storage diseases correlates with abnormal accumulation of GM2 ganglioside. J. Neurochem. 62 (1994) 1852-1862
30. Russell C., Hendson G., Jevon G., Matlock T., Yu J., Aklujkar M., Ng K.Y., and Clarke L.A. Murine MPS I: insights into the pathogenesis of Hurler syndrome. Clin. Genet. 53 (1998) 349-361
31. Ellinwood N.M., Colle M.A., Weil M.A., Casal M.L., Vite C.H., Wiemelt S., Hasson C.W., O'Malley T.M., He X., Prociuk U., Verot L., Melniczek J.R., Lannon A., Aguirre G.D., Knox V.W., Evans S.M., Vanier M.T., Schuchman E.H., Walkley S.U., and Haskins M.E. Bone marrow transplantation for feline mucopolysaccharidosis I. Mol. Genet. Metab 91 (2007) 239-250
32. Dacremont G., Kint J.A., and Cocquyt G. Brain sphingolipids in I cell disease (mucolipidosis II). J. Neurochem. 22 (1974) 599-602
33. Zervas M., Dobrenis K., and Walkley S.U. Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations. J. Neuropathol. Exp. Neurol. 60 (2001) 49-64
34. McGlynn R., Dobrenis K., and Walkley S.U. Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders. J. Comp. Neurol. 480 (2004) 415-426
35. Walkley S.U., Thrall M.A., Haskins M.E., Mitchell T.W., Wenger D.A., Brown D.E., Dial S., and Seim H. Abnormal neuronal metabolism and storage in mucopolysaccharidosis type VI (Maroteaux-Lamy) disease. Neuropathol. Appl. Neurobiol. 31 (2005) 536-544
36. -/- Knockout Mouse Model (in press).
37. Goodman L.A., Livingston P.O., and Walkley S.U. Ectopic dendrites occur only on cortical pyramidal cells containing elevated GM2 ganglioside in α-mannosidosis. Proc. Natl. Acad. Sci. USA 88 (1991) 11330-11334
38. Walkley S.U. Pyramidal neurons with ectopic dendrites in storage diseases exhibit increased GM2 ganglioside immunoreactivity. Neuroscience 68 (1995) 1027-1035
39. Purpura D.P., and Suzuki K. Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease. Brain Res. 116 (1976) 1-21
40. Walkley S.U. Secondary accumulation of gangliosides in lysosomal storage disorders. Semin. Cell Dev. Biol. 15 (2004) 433-444
41. Walkley S.U. Pathogenic mechanisms in lysosomal disease: a reappraisal of the role of the lysosome. Acta Paediatr. Suppl. 96 (2007) 26-32
42. Vanier M.T., and Svennerholm L. Chemical pathlogy of Krabbe's disease. III. Ceramide-hexosides and gangliosides of brain. Ata Paediatr. Scand. 64 (1975) 641-648
43. Svennerholm L., Fredman P., Jungbjer B., Månsson J.E., Rynmark B.M., Boström K., Hagberg B., Noren L., and Santavuori P. Large alterations in ganglioside and neutral glycosphingolipid patterns in brains from cases with infantile neuronal ceroid lipofuscinosis/polyunsaturated fatty acid lipidosis. J. Neurochem. 49 (1987) 1772-1783
44. Philippart M. Glycolipid, mucopolysaccharide and carbohydrate distribution in tissues, plasma and urine from glycolipidoses and other disorders. In: Zambotti V., Tettamanti G., and Arrigoni M. (Eds). Adv. Exp. Med. Biol. Vol. 25 (1972), Plenum Press, New York 231-254
45. Dacremont G., Kint J.A., Carton D., and Cocquyt G. Glucosylceramide in plasma of patients with Niemann-Pick disease. Clin. Chim. Acta 52 (1974) 365-367
46. Vanier M.T. Biochemical studies in Niemann-Pick disease. I. Major sphingolipids of liver and spleen. Biochim. Biophys. Acta 750 (1983) 178-184
47. Nilsson O., Månsson J.E., Håkansson G., and Svennerholm L. The occurrence of psychosine and other glycolipids in spleen and liver from the three major types of Gaucher's disease. Biochim. Biophys. Acta 712 (1982) 453-463
48. Ghauharali-van der Vlugt K., Langeveld M., Poppema A., Kuiper S., Hollak C.E., Aerts J.M., and Groener J.E. Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease. Clin. Chim. Acta 389 (2008) 109-113
49. Hulkova H., Ledvinova J., Asfaw B., Koubek K., Kopriva K., and Elleder M. Lactosylceramide in lysosomal storage disorders: a comparative immunohistochemical and biochemical study. Virchows Arch. 447 (2005) 31-44
50. Vanier M., and Svennerholm L. Chemical pathology of Krabbe disease: the occurrence of psychosine and other neutral sphingoglycolipids. Adv. Exp. Med. Biol. 68 (1976) 115-126
51. Svennerholm L., Vanier M.T., and Månsson J.E. Krabbe disease: a galactosylsphingosine (psychosine) lipidosis. J. Lipid Res. 21 (1980) 53-64
52. Igisu H., and Suzuki K. Progressive accumulation of toxic metabolite in a genetic leukodystrophy. Science 224 (1984) 753-755
53. Nilsson O., and Svennerholm L. Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease. J. Neurochem. 39 (1982) 709-718
54. Orvisky E., Park J.K., LaMarca M.E., Ginns E.I., Martin B.M., Tayebi N., and Sidransky E. Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype. Mol. Genet. Metab. 76 (2002) 262-270
55. Neuenhofer S., Conzelmann E., Schwarzmann G., Egge H., and Sandhoff K. Occurrence of lysoganglioside lyso-GM2 (II3-Neu5Ac-gangliotriaosylsphingosine) in GM2 gangliosidosis brain. Biol. Chem. Hoppe Seyler 367 (1986) 241-244
56. Rosengren B., Månsson J.E., and Svennerholm L. Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease?. J. Neurochem. 49 (1987) 834-840
57. Toda K., Kobayashi T., Goto I., Ohno K., Eto Y., Inui K., and Okada S. Lysosulfatide (sulfogalactosylsphingosine) accumulation in tissues from patients with metachromatic leukodystrophy. J. Neurochem. 55 (1990) 1585-1591
58. Aerts J.M., Groener J.E., Kuiper S., Donker-Koopman W.E., Strijland A., Ottenhoff R., van Roomen C., Mirzaian M., Wijburg F.A., Linthorst G.E., Vedder A.C., Rombach S.M., Cox-Brinkman J., Somerharju P., Boot R.G., Hollak C.E., Brady R.O., and Poorthuis B.J. Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc. Natl. Acad. Sci. U. S. A 105 (2008) 2812-2817
59. Suzuki K. Twenty five years of the "psychosine hypothesis": a personal perspective of its history and present status. Neurochem. Res. 23 (1998) 251-259
60. Goldin E., Roff C.F., Miller S.P., Rodriguez-Lafrasse C., Vanier M.T., Brady R.O., and Pentchev P.G. Type C Niemann-Pick disease: a murine model of the lysosomal cholesterol lipidosis accumulates sphingosine and sphinganine in liver. Biochim. Biophys. Acta 1127 (1992) 303-311
61. Rodriguez-Lafrasse C., Rousson R., Pentchev P.G., Louisot P., and Vanier M.T. Free sphingoid bases in tissues from patients with type C Niemann-Pick disease and other lysosomal storage disorders. Biochim. Biophys. Acta 1226 (1994) 138-144
62. te Vruchte D., Lloyd-Evans E., Veldman R.J., Neville D.C., Dwek R.A., Platt F.M., van Blitterswijk W.J., and Sillence D.J. Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport. J. Biol. Chem. 279 (2004) 26167-26175
63. Rodriguez-Lafrasse C., Rousson R., Valla S., Antignac P., Louisot P., and Vanier M.T. Modulation of protein kinase C by endogenous sphingosine: inhibition of phorbol dibutyrate binding in Niemann-Pick C fibroblasts. Biochem. J 325 Pt. 3 (1997) 787-791
64. Beltroy E.P., Liu B., Dietschy J.M., and Turley S.D. Lysosomal unesterified cholesterol content correlates with liver cell death in murine Niemann-Pick type C disease. J. Lipid Res. 48 (2007) 869-881
65. Kulinski A., and Vance J.E. Lipid homeostasis and lipoprotein secretion in Niemann-Pick C1-deficient hepatocytes. J. Biol. Chem. 282 (2007) 1627-1637
66. Slotte J.P., Pörn I., and Härmälä A.S. Flow and distribution of cholesterol-effects of phospholipids. In: Hoekstra D. (Ed). Cell Lipids. Current Topics in membranes Vol. 40 (1994), Acad. press, New York 483-502
67. Puri V., Watanabe R., Dominguez M., Sun X., Wheatley C.L., Marks D.L., and Pagano R.E. Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases. Nat. Cell Biol. 1 (1999) 386-388
68. Pagano R.E. Endocytic trafficking of glycosphingolipids in sphingolipid storage diseases. Philos. Trans. R. Soc. Lond B Biol. Sci. 358 (2003) 885-891
69. Liscum L., and Faust J.R. The intracellular transport of low density lipoprotein-derived cholesterol is inhibited in Chinese hamster ovary cells cultured with 3-beta-[2-(diethylamino)ethoxy]androst-5-en-17-one. J. Biol. Chem. 264 (1989) 11796-11806
70. Rodriguez-Lafrasse C., Rousson R., Bonnet J., Pentchev P.G., Louisot P., and Vanier M.T. Abnormal cholesterol metabolism in imipramine-treated fibroblast cultures. Similarities with Niemann-Pick type C disease. Biochim. Biophys. Acta 1043 (1990) 123-128
71. Roff C.F., Goldin E., Comly M.E., Cooney A., Brown A., Vanier M.T., Miller S.P., Brady R.O., and Pentchev P.G. Type C Niemann-Pick disease: use of hydrophobic amines to study defective cholesterol transport. Dev. Neurosci. 13 (1991) 315-319
72. Butler J.D., Blanchette-Mackie J., Goldin E., O'Neill R.R., Carstea G., Roff C.F., Patterson M.C., Patel S., Comly M.E., and Cooney A. Progesterone blocks cholesterol translocation from lysosomes. J. Biol. Chem. 267 (1992) 23797-23805
73. Lange Y., Ye J., Rigney M., and Steck T. Cholesterol movement in Niemann-Pick type C cells and in cells treated with amphiphiles. J. Biol. Chem. 275 (2000) 17468-17475
74. Fredman P., Klinghardt G.W., Nilsson O., and Svennerholm L. Lipid accumulation in liver, spleen, lungs and kidneys of miniature-pigs after chloroquine treatment. Biochem. J. 201 (1982) 581-588
75. Besley G.T., and Elleder M. Enzyme activities and phospholipid storage patterns in brain and spleen samples from Niemann-Pick disease variants: a comparison of neuropathic and non-neuropathic forms. J. Inherit. Metab Dis. 9 (1986) 59-71
76. Morell P., and Jurevics H. Origin of cholesterol in myelin. Neurochem. Res. 21 (1996) 463-470
77. Dietschy J.M., and Turley S.D. Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res. 45 (2004) 1375-1397
78. Vance J.E., Karten B., and Hayashi H. Lipid dynamics in neurons. Biochem. Soc. Trans. 34 (2006) 399-403
79. Karten B., Vance D.E., Campenot R.B., and Vance J.E. Cholesterol accumulates in cell bodies, but is decreased in distal axons, of Niemann-Pick C1-deficient neurons. J. Neurochem. 83 (2002) 1154-1163
80. Reid P.C., Sakashita N., Sugii S., Ohno-Iwashita Y., Shimada Y., Hickey W.F., and Chang T.Y. A novel cholesterol stain reveals early neuronal cholesterol accumulation in the Niemann-Pick type C1 mouse brain. J. Lipid Res. 45 (2004) 582-591
81. Crawley A.C., and Walkley S.U. Developmental analysis of CNS pathology in the lysosomal storage disease alpha-mannosidosis. J. Neuropathol. Exp. Neurol. 66 (2007) 687-697
82. Pentchev P.G., Blanchette-Mackie E.J., and Dawidowicz E.A. The NP-C gene: a key to pathways of intracellular cholesterol transport. Trends Cell Biol. 4 (1994) 365-369
83. Gondre-Lewis M.C., McGlynn R., and Walkley S.U. Cholesterol accumulation in NPC1-deficient neurons is ganglioside dependent. Curr. Biol. 13 (2003) 1324-1329
84. Liu Y., Wu Y.P., Wada R., Neufeld E.B., Mullin K.A., Howard A.C., Pentchev P.G., Vanier M.T., Suzuki K., and Proia R.L. Alleviation of neuronal ganglioside storage does not improve the clinical course of the Niemann-Pick C disease mouse. Hum. Mol. Genet. 9 (2000) 1087-1092
85. Li H., Turley S.D., Liu B., Repa J.J., and Dietschy J.M. GM2/GD2 and GM3 gangliosides have no effect on cellular cholesterol pools or turnover in normal or NPC1 mice. J Lipid Res. 49 (2008) 1816-1828
86. Kobayashi T., Beuchat M.H., Lindsay M., Frias S., Palmiter R.D., Sakuraba H., Parton R.G., and Gruenberg J. Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport. Nat. Cell Biol. 1 (1999) 113-118
87. Rouser G., Kritchevsky G., Knudson Jr. A.G., and Simon G. Accumulation of a glycerolphospholipid in classical Niemann-Pick disease. Lipids 3 (1968) 287-290
88. Wiedemann H.R., Debuch H., Lennert K., Caesar R., Blumcke S., Harms D., Tolksdorf M., Seng P.N., Korenke H.D., Gerken H., Freitag F., and Dorner K. [An infantile-juvenile, subchronically progressive lipoidosis of the sphingomyelinoses (Niemann-Pick) form-a new type? Clinical, pathohistological, electron microscopic and biochemical studies]. Z. Kinderheilkd. 112 (1972) 187-225
89. Wenger D.A., Barth G., and Githens J.H. Nine cases of sphingomyelin lipidosis, a new variant in Spanish-American Children. Juvenile variant of Niemann-Pick Disease with foamy and sea-blue histiocytes. Am. J. Dis. Child 131 (1977) 955-961
90. Lüllmann-Rauch R. Drug-induced lysosomal storage disorders. In: Dingle J.T., Jacques P.J., and Shaw H. (Eds). Lysosomes in applied biology and therapeutics Vol. 6 (1979), Amsterdam, North Holland 49-130
91. Kahma K., Brotherus J., Haltia M., and Renkonen O. Low and moderate concentrations of lysobisphosphatidic acid in brain and liver of patients affected by some storage diseases. Lipids 11 (1976) 539-544
92. Käkelä R., Somerharju P., and Tyynela J. Analysis of phospholipid molecular species in brains from patients with infantile and juvenile neuronal-ceroid lipofuscinosis using liquid chromatography-electrospray ionization mass spectrometry. J. Neurochem. 84 (2003) 1051-1065
93. Klinghardt G.W., Fredman P., and Svennerholm L. Chloroquine intoxication induces ganglioside storage in nervous tissue: a chemical and histopathological study of brain, spinal cord, dorsal root ganglia, and retinal in the miniature pig. J. Neurochem. 37 (1981) 897-908
94. Crocker A.C., and Farber S. Niemann-Pick disease: a review of eighteen patients. Medicine (Baltimore) 37 (1958) 1-95
95. Thomas G.H., Tuck-Muller C.M., Miller C.S., and Reynolds L.W. Correction of sphingomyelinase deficiency in Niemann-Pick type C fibroblasts by removal of lipoprotein fraction from culture media. J. Inherit. Metab Dis. 12 (1989) 139-151
96. Vanier M.T., Rodriguez-Lafrasse C., Rousson R., Gazzah N., Juge M.C., Pentchev P.G., Revol A., and Louisot P. Type C Niemann-Pick disease: spectrum of phenotypic variation in disruption of intracellular LDL-derived cholesterol processing. Biochim. Biophys. Acta 1096 (1991) 328-337
97. Suzuki K., Suzuki K., and Kamoshita S. Chemical pathology of GM1 gangliosidosis (Generalized gangliosidosis). J. Neuropath. Exp. Neurol. 28 (1969) 27-73
98. Adachi M., and Volk B.W. The Gangliosidoses (1975), Plenum, New York 125-158
99. Kint J.A., Dacremont G., Carton D., Orye E., and Hooft C. Mucopolysaccharidosis: secondarily induced abnormal distribution of lysosomal isoenzymes. Science 181 (1973) 352-354
100. Avila J.L., and Convit J. Inhibition of leucocytic lysosomal enzymes by glycosaminoglycans in vitro. Biochem. J. 152 (1975) 57-64
101. Baumkotter J., and Cantz M. Decreased ganglioside neuraminidase activity in fibroblasts from mucopolysaccharidosis patients. Inhibition of the activity in vitro by sulfated glycosaminoglycans and other compounds. Biochim. Biophys. Acta 761 (1983) 163-170
102. Simons K., and Gruenberg J. Jamming the endosomal system: lipid rafts and lysosomal storage diseases. Trends Cell Biol. 10 (2000) 459-462
103. Sobo K., Blanc Le I., Luyet P.P., Fivaz M., Ferguson C., Parton R.G., Gruenberg J., and van der Goot F.G. Late endosomal cholesterol accumulation leads to impaired intra-endosomal trafficking. PLoS. ONE 2 (2007) e851
104. Kolter T., and Sandhoff K. Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. Annu. Rev. Cell Dev. Biol. 21 (2005) 81-103
105. Walkley S.U., and Suzuki K. Consequences of NPC1 and NPC2 loss of function in mammalian neurons. Biochim. Biophys. Acta 1685 (2004) 48-62
106. Salvioli R., Scarpa S., Ciaffoni F., Tatti M., Ramoni C., Vanier M.T., and Vaccaro A.M. Glucosylceramidase mass and subcellular localization are modulated by cholesterol in Niemann-Pick disease type C. J Biol. Chem. 279 (2004) 17674-17680
107. Chevallier J., Chamoun Z., Jiang G., Prestwich G., Sakai N., Matile S., Parton R.G., and Gruenberg J. Lysobisphosphatidic acid controls endosomal cholesterol levels. J. Biol. Chem. (2008)
108. Walkley S.U. Neurobiology and cellular pathogenesis of glycolipid storage diseases. Philos. Trans. R. Soc. Lond B Biol. Sci. 358 (2003) 893-904
109. Griffin L.D., Gong W., Verot L., and Mellon S.H. Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone. Nat. Med. 10 (2004) 704-711
110. Polo S., and Di Fiore P.P. Endocytosis conducts the cell signaling orchestra. Cell 124 (2006) 897-900
111. Bronfman F.C., Escudero C.A., Weis J., and Kruttgen A. Endosomal transport of neurotrophins: roles in signaling and neurodegenerative diseases. Dev. Neurobiol. 67 (2007) 1183-1203
112. McAllister A.K. Cellular and molecular mechanisms of dendrite growth. Cereb. Cortex 10 (2000) 963-973
113. Henderson L.P., Lin L., Prasad A., Paul C.A., Chang T.Y., and Maue R.A. Embryonic striatal neurons from Niemann-Pick type C mice exhibit defects in cholesterol metabolism and neurotrophin responsiveness. J. Biol. Chem. 275 (2000) 20179-20187
114. Barry M.F., and Ziff E.B. Receptor trafficking and the plasticity of excitatory synapses. Curr. Opin. Neurobiol. 12 (2002) 279-286
115. Bredt D.S., and Nicoll R.A. AMPA receptor trafficking at excitatory synapses. Neuron 40 (2003) 361-379
116. Isaac J.T., Ashby M., and McBain C.J. The role of the GluR2 subunit in AMPA receptor function and synaptic plasticity. Neuron 54 (2007) 859-871
117. Passafaro M., Nakagawa T., Sala C., and Sheng M. Induction of dendritic spines by an extracellular domain of AMPA receptor subunit GluR2. Nature 424 (2003) 677-681
118. d'Azzo A., Tessitore A., and Sano R. Gangliosides as apoptotic signals in ER stress response. Cell Death. Differ. 13 (2006) 404-414
119. Ginzburg L., Kacher Y., and Futerman A.H. The pathogenesis of glycosphingolipid storage disorders. Semin. Cell Dev. Biol. 15 (2004) 417-431
120. Hannun Y.A., and Bell R.M. Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. Science 235 (1987) 670-674
121. M. Walter, F.W. Chen, F. Tamari, R. Wang, Y.A. Ioannou, Endosomal lipid accumulation in NPC1 leads to inhibition of PKC, hypophosphorylation of vimentin and Rab9 entrapment, Biol. Cell. in press.
122. Lloyd-Evans E., Morgan A.J., He X., Smith D.A., Elliot-Smith E., Sillence D.J., Churchill G.C., Schuchman E.H., Galione A., and Platt F.M. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat. Med. 14 (2008) 1247-1255
123. Walkley S.U. Pathogenic cascades and brain dysfunction. In: Platt F.M., and Walkley S.U. (Eds). Lysosomal Disorders of the Brain (2004), Oxford University Press, Oxford 290-324
124. Schwarzmann, and Sandhoff K. Metabolism and intracellular transport of glycosphingolipids. Biochemistry 29 (1990) 10865-10871
125. Tettamanti G., Bassi R., Viani P., and Riboni L. Salvage pathways in glycosphingolipid metabolism. Biochimie 85 (2003) 423-437
126. Hara T., Nakamura K., Matsui M., Yamamoto A., Nakahara Y., Suzuki-Migishima R., Yokoyama M., Mishima K., Saito I., Okano H., and Mizushima N. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441 (2006) 885-889
127. Komatsu M., Waguri S., Chiba T., Murata S., Iwata J., Tanida I., Ueno T., Koike M., Uchiyama Y., Kominami E., and Tanaka K. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441 (2006) 880-884
128. Cuervo A.M. Autophagy: in sickness and in health. Trends Cell Biol. 14 (2004) 70-77
129. Pacheco C.D., and Lieberman A.P. Lipid trafficking defects increase Beclin-1 and activate autophagy in Niemann-Pick type C disease. Autophagy 3 (2007) 487-489
130. Pacheco C.D., Kunkel R., and Lieberman A.P. Autophagy in Niemann-Pick C disease is dependent upon Beclin-1 and responsive to lipid trafficking defects. Hum. Mol. Genet. 16 (2007) 1495-1503
131. Settembre C., Fraldi A., Jahreiss L., Spampanato C., Venturi C., Medina D., de Pablo R., Tacchetti C., Rubinsztein D.C., and Ballabio A. A block of autophagy in lysosomal storage disorders. Hum. Mol. Genet. 17 (2008) 119-129
132. Cao Y., Espinola J.A., Fossale E., Massey A.C., Cuervo A.M., MacDonald M.E., and Cotman S.L. Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis. J. Biol. Chem. 281 (2006) 20483-20493
133. Desmaris N., Verot L., Puech J.P., Caillaud C., Vanier M.T., and Heard J.M. Prevention of neuropathology in the mouse model of Hurler syndrome. Ann. Neurol. 56 (2004) 68-76
134. Ciron C., Desmaris N., Colle M.A., Raoul S., Joussemet B., Verot L., Ausseil J., Froissart R., Roux F., Cherel Y., Ferry N., Lajat Y., Schwartz B., Vanier M.T., Maire I., Tardieu M., Moullier P., and Heard J.M. Gene therapy of the brain in the dog model of Hurler's syndrome. Ann. Neurol. 60 (2006) 204-213
135. Cressant A., Desmaris N., Verot L., Brejot T., Froissart R., Vanier M.T., Maire I., and Heard J.M. Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum. J. Neurosci. 24 (2004) 10229-10239
136. Frisella W.A., O'Connor L.H., Vogler C.A., Roberts M., Walkley S., Levy B., Daly T.M., and Sands M.S. Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII. Mol. Ther. 3 (2001) 351-358
137. Meikle P.J., Duplock S., Blacklock D., Whitfield P.D., Macintosh G., Hopwood J.J., and Fuller M. Effect of lysosomal storage on bis(monoacylglycero)phosphate. Biochem. J. 411 (2008) 71-78